Key Takeaways
- Volume recovery underway, war clouds linger: Q4 revenue hit a record ₹736 cr on 15% QoQ volume growth after maintenance ended, but the West Asia conflict-driven price bump barely touched Q4 and will land in Q1 FY27.
- FY27 volume growth targeted at 10–12%: Management is confident barring major war escalation, with growth led by higher-value products; FY26 volumes fell ~4% on maintenance, monsoon and PVC volatility.
- Chlorine integration is the margin story: ECH and CPVC capacity doubling commissions in Q2 FY27, and by FY28 captive chlorine consumption is expected to hit 90–95%, up from 75% today.
- Chlorotoluene enters the revenue mix: Commissioned March 2025, ramping month-on-month; FY27 will see a sizeable contribution, with ~40% utilization targeted for the year and 70–75% by FY28.
- What to watch next quarter: Whether the war-driven price increase flows through to realizations as expected, the pace of Chlorotoluene volume pickup from May, and any announcement on the new greenfield project.
Volume Recovery & Demand Environment
- Q4 as the reset quarter: Major once-in-8-years maintenance completed in Q3, so the caustic soda plant ran at optimum levels; utilization jumped from 67–70% pre-November to 78–85% post-November.
- FY26 volume drag is now behind: The ~4% full-year volume decline had three resolved causes: prolonged monsoon hurting CPVC demand, PVC price volatility from anti-dumping duty and BIS uncertainty, and a subdued real estate market post-2024 election.
- April softness, May pickup: April volumes were a bit low as customers turned cautious on higher inventory costs; growth is picking up from May onwards.
- Product basket resilience: 60% of the basket goes into basic necessities where demand holds even at elevated prices; the remaining 40% sees some demand restriction, a mix management says leaves the company better off than peers.
- War-driven price increase lands in Q1: The escalation announced around end-February/early March had minimal Q4 impact because orders were already booked; only spot and one-week-ahead orders benefited. The ECU of caustic soda remained around ₹30,000.
Milind Kotecha: "So to put it short, the price increase because of war will be majorly reflected in Q1 and not in Q4."
Chlorine Integration & Capacity Expansion
- ECH and CPVC capacity doubling on track: Commissioning expected in Q2 FY27; both will start at low utilization of 15–20% and ramp gradually each quarter toward optimum levels of ~80% for ECH and ~75% for CPVC in FY28.
- Chlorine captive consumption target: Currently at 75%, expected to reach 90–95% by FY28 once ECH and CPVC capacities hit optimum utilization, materially reducing merchant chlorine exposure.
- Chlorotoluene ramp-up progressing: Facility commissioned in March 2025; passed customer approval and testing; orders were increasing from January but war impacted recent months; volume growth expected from May onwards.
- Chlorotoluene contribution trajectory: FY27 will see a sizeable contribution with utilization around 40%; optimum utilization of 70–75% targeted for FY28.
- New greenfield project under evaluation: One project selected, due diligence underway; announcement expected this year to ensure consistent growth beyond FY29–FY30.
Milind Kotecha: "So definitely I'm sure that we will be freezing on something and announcing this year so that we can have a consistent growth beyond FY29, FY30 onwards."
Margins & Cost Structure
- Q4 margin normalization: EBITDA margin at 23% on better plant sweating and normalized raw material prices; West Asia conflict drove up both raw material and finished good prices but Q4 impact remained minimal.
- Inflationary pressure ahead: War-driven raw material price increases expected to reflect in coming quarters; even if a ceasefire holds, management estimates 4–5 months for realizations across all products to stabilize.
- Interest cost spike was mark-to-market, not structural: ₹72 cr interest cost versus a guided ₹45–50 cr came from a foreign exchange derivative swap where INR depreciation far exceeded the historical 2–3% annual rate; management is working on mitigating future such impacts.
- Margin guidance withheld: Management declined to give EBITDA margin guidance, stating only that achieved levels would be maintained in that range.
Milind Kotecha: "even if it ends, it will take time to stabilize and it's not going to happen in a -- immediate basis"
Renewable Energy & Power
- Wind-solar hybrid expansion: An additional 19.50 MW of wind-solar capacity is being added; once commissioned and at optimum level, approximately 15% of the company's power requirement will come from wind-solar hybrid sources.
- Industry benchmarking unavailable: When asked for the renewable energy share among Indian caustic soda peers, management did not have the number on hand.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Volume growth | 10–12% volume growth, barring major war escalation | FY27 |
| ECH and CPVC capacity commissioning | Capacity doubling commissioned | Q2 FY27 |
| Chlorine captive consumption | Reach 90–95% (from 75% today) | FY28 (at optimum utilization) |
| Chlorotoluene utilization | ~40% utilization | FY27 |
| Chlorotoluene optimum utilization | 70–75% utilization | FY28 |
| CPVC optimum utilization | ~75% utilization | FY28 |
| ECH optimum utilization | ~80% utilization | FY28 |
| Wind-solar hybrid share | ~15% of total power requirement | Once new 19.50 MW capacity at optimum |
| New greenfield project announcement | Project freeze and public announcement | This year (calendar not specified) |
| Post-war realization stabilization | Realizations across all products to stabilize | 4–5 months after ceasefire holds |
Key Metrics
| Metric | Q4 FY26 |
|---|---|
| Revenue | ₹736 cr, highest ever, +22% QoQ |
| Volume growth | 15% QoQ, 14% YoY |
| EBITDA | ₹169 cr, +64% QoQ vs ₹103 cr in Q3 |
| EBITDA margin | 23%, normalized on better plant utilization and raw material costs |
| PAT | ₹82 cr, vs ₹35 cr in Q3 |
| PAT margin | 11% |
| Derivatives and specialty revenue share | 54%, vs 52% in Q3 |
| Full-year FY26 revenue | ₹2,542 cr, down 1% YoY on 4% volume drop |
| Full-year FY26 EBITDA | ₹567 cr, vs ₹711 cr in FY25 |
| Full-year FY26 EBITDA margin | 22% |
| Full-year FY26 PAT | ₹330 cr, includes one-time deferred tax benefit of ₹81 cr; excluding that, ₹252 cr vs ₹357 cr in FY25 |
| Full-year FY26 ROCE | 16%; excluding CWIP of ₹451 cr, 17% |
| Net debt to EBITDA | 0.9x as on 31 Mar 2026, vs 0.7x previous year |
| Net debt | ₹508 cr, vs ₹489 cr previous year |
| Capex spent during the year | ₹394 cr |
| Cash generated from operations | ₹436 cr |
| Realized ECU (caustic soda) | ~₹30,000 in Q4; current ECU ~₹37,000 post-war |
| Caustic soda price increase | 30% to 35% vs pre-war levels |
| Chlorine captive consumption | 75% currently; expected to reach 90% to 95% after ECH and CPVC ramp-up |
| Wind-solar share in power consumption | 8% to 9% currently; expected ~15% after 19.50 MW addition |
| Volume growth target | 10% to 12% for FY27 |
| Chlorotoluene utilization | Minuscule in FY26; expected ~40% in FY27, optimum 70% to 75% in FY28 |
| CPVC and ECH current utilization | Around optimum, in the range of 65% to 80% |
| CPVC optimum utilization | ~75% |
| ECH optimum utilization | ~80% |
| Chloromethanes price hike | ~50% (post-quarter, to be reflected in Q1 FY27) |
| Full-year FY26 interest cost | ₹72 cr, higher than earlier guided ₹45 cr to ₹50 cr due to mark-to-market impact on foreign exchange derivative |
| Exports share | 4% to 5% of total revenue, mostly to Europe |